GD Wins U.S Army Medical Research And Development Contract

General Dynamics Information Technology has been awarded a $41.8 million task order by the U.S. Army Medical Research Materiel Command to provide support services for vaccine, drug and medical device development programs to the U.S. Army Medical Materiel Development Activity (USAMMADA). GD will deliver a wide range of services along with partner Tunnell Government Services Inc to help the USAMMDA guide new medical technologies through the U.S. Food and Drug Administration regulatory and certification process and develop plans to bring these new products into service. The companies will provide health, medical research, clinical trial and regulatory expertise as well as information, acquisition and program management support services. "Medical research plays a critical role in ensuring that U.S. servicemen and servicewomen are protected before, during and after a mission," said Marcus Collier, senior vice president, Health and Civilian Solutions division, General Dynamics Information Technology. "Our unique combination of health, military and IT expertise will help the USAMMDA develop new leading-edge medical solutions". USAMMDA develops new drugs, vaccines and medical support devices that enhance readiness, ensure provisions of the highest quality medical care to the DoD and maximize the survival of medical casualties on the battlefield.